Pelvic pain syndromes

1. GLP-1 receptor agonists lower the risk of pelvic pain syndromes in humans (7.03% vs 11.98%; OR 0.555, 95% CI 0.465–0.663).

   “pelvic pain syndromes (7.03% vs 11.98%; OR 0.555, 95% CI 0.465–0.663, p < 0.0001)”

   Humansin non-diabetic postpartum womenfemalesn = 5,387

   Association Between GLP-1 Receptor Agonist Use and Postpartum Pelvic Complications: A Global Matched Cohort Study

   Research Square·20 Aug 2026Preprint

More on GLP-1 receptor agonists